In the prevalence table, Japanese individuals had a higher mutation-positive rate for BRCA1/2 than Americans (except for Ashkenazi Jews) in almost all groups except for the male breast carcinoma groups. This evidence concerns the gene BRCA1 and breast carcinoma.